mRNA |
paclitaxel |
CCLE |
pan-cancer |
AAC |
-0.12 |
0.008 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.01 |
mRNA |
UNC1215 |
GDSC1000 |
pan-cancer |
AAC |
-0.092 |
0.01 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.01 |
mRNA |
Nilotinib |
CCLE |
pan-cancer |
AAC |
-0.13 |
0.01 |
mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.01 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.01 |
mRNA |
BMS-536924 |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.01 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.01 |
mRNA |
etomoxir |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.02 |